Press Releases

Recent & Archived News

February 15, 2019

Bayer to obtain full rights to global development and commercialization of oncology compounds Vitrakvi® (larotrectinib) and BAY 2731954 (LOXO-195)

Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and...

Learn more
February 14, 2019

Bayer's investigational drug darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer

Results from the pivotal Phase III ARAMIS trial in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) showed a statistically significant improvement in metastasis-free...

Learn more
February 13, 2019

Bayer donates $130,000 to 13 domestic violence shelters through new Grants Fur Families program

Bayer announces 13 domestic violence shelters that are receiving funding through Grants Fur Families, a new program providing life-saving support to domestic violence shelters across the country...

Learn more
February 13, 2019

Bayer and Geisinger partner to create contraception counseling pathway to improve overall contraceptive care for women

Bayer, a longstanding leader in women's healthcare, and Geisinger are partnering to create a contraception counseling pathway within the Geisinger Electronic Health Record (EHR) with the aim of...

Learn more
February 07, 2019

Bayer's Ray Kerins Elected Chairman of U.S. Chamber of Commerce's Global Innovation Policy Center

Bayer U.S. announced today that Raymond F. Kerins, Jr., Senior Vice President of Corporate Affairs, is the new Chairman of the U.S. Chamber of Commerce's Global Innovation Policy Center (GIPC). In...

Learn more
February 05, 2019

Bayer to Showcase New Data from its Growing Cancer Portfolio at 2019 ASCO GU Cancers Symposium

Bayer announced today that research on its growing cancer portfolio will be presented at the 2019 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium taking place...

Learn more
January 31, 2019

Monsanto Fund and Operation Food Search Unveil New Nutritional Program Focused on Healthy Pregnancies

To address issues associated with food insecurity during pregnancy for low-income women and their families, the Monsanto Fund (a philanthropic arm of Bayer) and St. Louis-based Operation Food...

Learn more
January 18, 2019

Bayer introduces versatile new option for heartworm prevention and intestinal parasite control

Bayer Animal Health announces the launch of Coraxis™ (moxidectin) Topical Solution for Dogs, a prescription-only, monthly transdermal product that prevents heartworm disease and treats and...

Learn more
January 17, 2019

Farm for the Good™ of Your Community

Growers, the economic drivers of our rural economies, can kick in a power thrust with the Farm for Good™ Sweepstakes, presented by Bayer. Growers now can enter for a chance to win a $5,000...

Learn more
January 16, 2019

Bayer to Highlight New Research at ASCO GI 2019 Cancers Symposium

Bayer will present new data from its continued research on Stivarga® (regorafenib) in metastatic colorectal cancer (mCRC) and metastatic biliary tract cancers, and Nexavar® (sorafenib) in...

Learn more

 

Want even more Bayer news?

Check out our Social Media & Blogs.